Notifications
Back

Pipeline

Foot-and-Mouth Vaccine (VXD1-FMDV)

Our Pipeline

Vaxdigm presents a new production standard for next-gen biomaterials and progresses the manufacturing paradigm for global bio industry


Foot-and-Mouth Vaccine (VXD1-FMDV)

Material Recombinant protein nanoparticle vaccine
Indication Foot-and-Mouth
Development progress
Identification of contesting materials Preclinical Stage 1 clinical

Our Pipeline

Vaxdigm presents a new production standard for next-gen biomaterials and progresses the manufacturing paradigm for global bio industry


 Foot-and-Mouth Vaccine (VXD1-FMDV)

Material Recombinant protein nanoparticle vaccine
Indication Foot-and-Mouth
Development progress
Identification of contesting materials Preclinical Stage 1 clinical


Vaxdigm Co., Ltd.

CEO Sung Jae Kim

TEL 02-6205-2550

EMAIL hydrogold@vaxdigm.com

BUSINESS NUMBER 657-87-02464

ADDRESS 412ho, 201, Songpa-daero, Songpa-gu, Seoul, Republic of Korea

PRIVACY POLICYㅣTERMS AND CONDITIONS

COPYRIGHT © 2026 VAXDIGM. ALL RIGHTS RESERVED.


Vaxdigm Co., Ltd. 

CEO Sung Jae Kim

EMAIL hydrogold@vaxdigm.com ㅣ TEL 02-6205-2550

BUSINESS NUMBER 657-87-02464 ㅣ ADDRESS 412ho, 201, Songpa-daero, Sonpa-gu, Seoul, Republic of Korea

PRIVACY POLICYㅣTERMS AND CONDITIONS

COPYRIGHT © 2026 VAXDIGM. ALL RIGHTS RESERVED.